Shalby Limited SHALBY
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Daily technical summary
Calculated in the browser from validated historical candles. This is descriptive research, not a buy or sell recommendation.
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 1,839.13 | 1,703.62 | 1,607.53 |
| Cash Equivalents | 0.03 | Not available | 0 |
| Other Liabilities Total | 14.85 | 14.6 | 14.58 |
| Accrued Expenses | 4.42 | 18 | 17.29 |
| Long Term Debt | 152.88 | 136.67 | 175.97 |
| Common Stock Total | 107.52 | 107.49 | 107.41 |
| Other Current Assets Total | 20.71 | 0.06 | 0.07 |
| Total Assets | 1,839.13 | 1,703.65 | 1,607.53 |
| Current Portof LT Debt/Capital Leases | 400.25 | 60 | 47.02 |
| Cash | 21.9 | 34.79 | 27.18 |
| Total Equity | 1,005.23 | 992.19 | 1,000.37 |
| Long Term Investments | 12.39 | 11.19 | 2.71 |
| Retained Earnings(Accumulated Deficit) | 897.71 | 447.67 | 454.01 |
| Total Common Shares Outstanding | 10.73 | 10.75 | 10.74 |
| Tangible Book Valueper Share Common Eq | 85.44 | 84.77 | 86.15 |
| Goodwill Net | 56.86 | 56.86 | 56.86 |
| Total Liabilities | 833.9 | 711.43 | 607.16 |
| Total Debt | 594.59 | 475.93 | 377.86 |
| Short Term Investments | 71.87 | 103.4 | 132.08 |
| Cashand Short Term Investments | 93.81 | 138.18 | 159.26 |
| Total Receivables Net | 228.42 | 183.98 | 151 |
| Deferred Income Tax | 48.55 | 63.14 | 35.02 |
| Accounts Receivable-Trade Net | 228.42 | 175.35 | 145.44 |
| Property/Plant/Equipment Total-Net | 976.19 | 896.37 | 906.54 |
| Minority Interest | 0.46 | 3.14 | 7.41 |
| Total Current Liabilities | 575.69 | 455.29 | 323.26 |
| Total Inventory | 376.38 | 331.63 | 238.8 |
| Accounts Payable | 128.49 | 118.42 | 129.57 |
| Other Currentliabilities Total | 42.54 | 18.21 | 25.42 |
| Total Long Term Debt | 194.34 | 175.27 | 226.89 |
| Intangibles Net | 31.65 | 24.13 | 18.2 |
| Other Long Term Assets Total | 36.51 | 12.83 | 18.15 |
| Note Receivable-Long Term | 6.2 | 44.31 | 52.83 |
| Total Current Assets | 719.33 | 657.96 | 552.25 |
| Capital Lease Obligations | 41.46 | 38.6 | 50.91 |
| Accumulated Depreciation Total | Not available | -359.76 | -308.5 |
| Other Equity Total | Not available | -1.72 | 0.93 |
| Prepaid Expenses | Not available | 4.12 | 3.13 |
| Additional Paid-In Capital | Not available | 438.76 | 438.03 |
| Property/Plant/Equipment Total-Gross | Not available | 1,248.08 | 1,204.39 |
| Notes Payable/Short Term Debt | Not available | 240.66 | 103.96 |
| Unrealized Gain(Loss) | Not available | -0.01 | -0.01 |
Valuation and ratios
Growth
Debt 5Yr CAGR %61.5
Margins
Operating Margin 12m6.38
Operating Margin 5y Avg9.34
Net Profit Margin 12m3.04
Net Profit Margin 5y5.18
Yield
Dividend Yield %0
Valuation
Price to Sale Ratio0.16
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk40.97
Recommendations
RatingBuy
Target High274.5
Target Low125.7
Target Mean2
Target Median25
Analyst count, source and as-of date are not provided; target values should be treated as unverified.Peer comparison
Only peers present in the company profile payload are displayed.
| Symbol | Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|---|
| — | Apollo Hospitals Enterprise | INR 8,911.8 | 1.28 L | 64.93 | — |
| — | Max Healthcare Institute | INR 1,087.15 | 1.06 L | 71.47 | — |
| — | Fortis Healthcare | INR 955.6 | 72,073.21 | 67.89 | — |
| — | Aster DM Healthcare | INR 800.45 | 41,232.03 | 102.55 | — |
| — | Narayana Hrudayalaya | INR 1,972.75 | 40,158.39 | 48.07 | — |
Ownership
- Promoter
- 74.33%
- FII
- 4.47%
- MF
- 0.01%
- Other
- 21.19%
Events
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
- annual General MeetingPOM
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
- annual General MeetingPOM
- board MeetingsTo consider other business matters.
- board MeetingsQuarterly Results
- annual General MeetingRs.1.2000 per share(12%)Final Dividend & A.G.M.
- dividendRs.1.2000 per share(12%)Final Dividend
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingRs.1.2000 per share(12%)Final Dividend & A.G.M.
- dividendRs.1.2000 per share(12%)Final Dividend
- board MeetingsQuarterly Results
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Stocks to buy or sell: Sumeet Bagadia has recommended buying these breakout stocks today — Shilpa Medicare, Marksans Pharma, Ahluwalia Contracts, Shalby, and BEPL
Shares of Shalby, India’s leading multi-specialty hospital, have gained 124% in the last six months, moving from ₹ 139 to ₹ 311.15 per share. In today's trading session, the stock jumped 1.7% to hit a new record high of ₹ 323.60 apiece.
Q2 Result Preview: Better occupancy rates, improving average revenues per operating bed (APROB) are the key reasons which keep analysts positive on better performance by hospitals during Q2. Apollo, Fortis, Medanta (Global Health), Shalby, rainbow are amongst analysts top picks
Day trading stocks: Market experts have recommended six stocks to buy today — HUL, DMart, Shalby, RBL Bank, Maruti Suzuki and Dr Lal Pathlabs
SOCE is an opportunity for young and budding orthopedists from across regions as Shalby Hospitals opens doors to share its expertise with them.
Business information
Shalby Limited is an India-based company, which operates multi-specialty hospital chains. The Company is engaged in the business of setting up and managing hospitals and medical diagnostic services. The Company’s Hospitals divisions include Multispecialty, Shalby Orthopedics Centre of Excellence (SOCE), Shalby Homecare, and Shalby Academy. Its Slaney Healthcare (Surgical & Pharma Products) divisions include Hosply (Hospital Supplies). Its Shalby MedTech divisions include Shalby Advanced Technologies Inc., USA (SAT), and Shalby Global Technologies PTE Ltd, Singapore (SGT). The Company offers a range of specialties, which include Bone and Joint, Cardiac Sciences, Cosmetic and Aesthetic, Dental Cosmetic and Implantology, Dermatology, Emergency Medicine, ENT Surgery, Gastro Sciences, General Medicine, General Surgery, Infertility and IVF, Intensive and Critical Care, Kidney Sciences, Liver Transplantation, Maxillofacial Surgery, Obstetrics and Gynaecology, Onco Sciences, and more.
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- Website
- Not available
- Address
- Not available
- NSE Code
- SHALBY
- BSE Code
- 540797
AI analysis
This repository contains no authenticated model-inference API, model version, confidence distribution or forecast timestamp. The Android listing is available; verify report availability, entitlement and pricing inside the app.
Open Google PlayStock FAQ
What is the symbol and ISIN of Shalby?
Shalby has the symbol SHALBY and ISIN - INE597J01018.
What is the current price of Shalby?
Shalby is currently trading at INR 163.46.
What are the year high and year low of Shalby?
Shalby has a year high of INR 274.50 and a year low of INR 125.70.
What is the market capitalization of Shalby?
Shalby has a market capitalization of INR 1,780.49 crore.
What is the P/E ratio of Shalby?
Shalby has a P/E ratio of 36.45.
What is the dividend yield of Shalby?
Shalby has a dividend yield of 0.00%.
How is the financial performance of Shalby based on revenue, net income, and EPS?
Shalby has revenue of INR 11,414.29 crore, net income of INR 373.88 crore, and EPS of INR 3.48.
What is the book value of Shalby?
Shalby has a book value of INR 85.44.
What is the debt-to-equity ratio of Shalby?
Shalby has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Shalby?
Shalby has a price-to-book ratio of 1.91 and a price-to-sales ratio of 0.16.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.

